Direct modulation of ErbB signalling mechanisms could explain the many discrepant opioid effects on cell growth and apoptosis observed so far in individual cell systems and may provide a novel strategy to stabilize certain ErbB dimers in order to enhance the sensitivity of ErbB-directed anti-tumour therapies and to avoid the development of drug resistance by preventing escape mechanisms. This evidence concerns the gene EGFR and neoplasm.